Simplicity Solutions’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$15.7M Buy
271,382
+3,010
+1% +$161K 0.43% 40
2023
Q3
$14.2M Buy
268,372
+6,571
+3% +$345K 0.46% 39
2023
Q2
$14.2M Buy
261,801
+4,420
+2% +$231K 0.39% 48
2023
Q1
$12.9M Buy
257,381
+245,674
+2,099% +$11.6M 0.34% 53
2022
Q4
$542K Buy
11,707
+1,786
+18% +$77.3K 0.07% 319
2022
Q3
$384K Buy
9,921
+1,893
+24% +$75.9K 0.06% 379
2022
Q2
$299K Sell
8,028
-361
-4% -$14.7K 0.04% 441
2022
Q1
$372K Sell
8,389
-5,189
-38% -$225K 0.05% 380
2021
Q4
$576K Buy
13,578
+6,779
+100% +$285K 0.06% 344
2021
Q3
$295K Buy
6,799
+2,030
+43% +$89.8K 0.05% 444
2021
Q2
$204K Buy
+4,769
New +$201K 0.04% 497
2021
Q1
Sell
-63,329
Closed -$2.28M 540
2020
Q4
$2.28M Buy
63,329
+22,143
+54% +$798K 0.03% 360
2020
Q3
$1.57M Buy
41,186
+1,030
+3% +$39.7K 0.03% 390
2020
Q2
$1.41M Buy
40,156
+4,394
+12% +$158K 0.03% 377
2020
Q1
$1.17M Buy
+35,762
New +$1.4M 0.04% 312

Other funds holding BSX

Simplicity Solutions's BSX Position: Q4 2023 in Review

Simplicity Solutions increased its Boston Scientific (BSX) stake by 1.1% in Q4 2023, buying an estimated $161K and bringing the position to 271,382 shares worth $15.7M. The position accounts for 0.43% of the portfolio, ranked #40.

Simplicity Solutions first reported a position in BSX in Q1 2020 and has held it in 15 quarters since. 1,150 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

  • Simplicity Solutions held 271,382 shares of Boston Scientific worth $15.7M as of Q4 2023.
  • Simplicity Solutions bought 3,010 Boston Scientific shares in Q4 2023, an estimated $161K.
  • Boston Scientific made up 0.43% of Simplicity Solutions's portfolio in Q4 2023, its #40 holding.
  • Simplicity Solutions first reported a position in Boston Scientific in Q1 2020 and has held it in 15 quarters since.
  • 1,150 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.